EUVIMEDEUVIMED entdecken
Open Access

Screening and identification of versican as a sensitive biomarker and potential therapeutic target in basal cell carcinoma

Wenlin Li, Yang Wang, Qiang Hu, Sainan Li, Dachuan Guo, Lin Liu, Xiuqing Huang, Lin Dou, Qi Zhou, Tao Shen, Jianmin Chang

International Journal of Medical Sciences · 2025

DOI: 10.7150/ijms.105650 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Medical Sciences, 2025. Verfasst von Wenlin Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Be…. Hauptthemen laut MEDLINE: Basal Cell Carcinoma, Skin Neoplasms, Biomarkers, Tumor, Versicans. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Basal Cell CarcinomaSkin NeoplasmsBiomarkers, TumorVersicansHumansAnimalsMiceGene Expression Regulation, NeoplasticCell Line, TumorTumor MicroenvironmentXenograft Model Antitumor AssaysGene Expression ProfilingApoptosisCell ProliferationMice, NudeCell MovementGene Knockdown Techniques

Stichwörter der Autor:innen

Basal cell carcinomaBioinformatics analysisTissue-specific key genesVCANdifferentially expressed genes

Substanzen

Biomarkers, TumorVersicansVCAN protein, human

Autor:innen und Institutionen

  • Department of Dermatology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
  • The Key Laboratory of Geriatrics, Beijing Institute of Geriatrics, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Hospital/National Center of Gerontology of National Health Commission, Bei…
  • School of life sciences, North China University of Science and Technology, Tangshan 063210, China.
  • Peking Union Medical College, Chinese Academy of Medical Sciences, Graduate School of Peking Union Medical College, Beijing, China.

Zitieren

APA

Li, W., Wang, Y., Hu, Q., Li, S., Guo, D., Liu, L., Huang, X., Dou, L., Zhou, Q., Shen, T., & Chang, J. (2025). Screening and identification of versican as a sensitive biomarker and potential therapeutic target in basal cell carcinoma. International Journal of Medical Sciences. https://doi.org/10.7150/ijms.105650

Vancouver

Li W, Wang Y, Hu Q, Li S, Guo D, Liu L, et al. Screening and identification of versican as a sensitive biomarker and potential therapeutic target in basal cell carcinoma. International Journal of Medical Sciences. 2025. doi:10.7150/ijms.105650

BibTeX
@article{Li2025,
  author = {Li, Wenlin and Wang, Yang and Hu, Qiang and Li, Sainan and Guo, Dachuan and Liu, Lin and Huang, Xiuqing and Dou, Lin and Zhou, Qi and Shen, Tao and Chang, Jianmin},
  title = {Screening and identification of versican as a sensitive biomarker and potential therapeutic target in basal cell carcinoma},
  journal = {International Journal of Medical Sciences},
  year = {2025},
  doi = {10.7150/ijms.105650}
}
Kostenlos starten →